Skip to content

Author

Dietlinde Wolf

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Could post-transplant cyclophosphamide benefit autoimmune disease patients following autologous hematopoietic stem cell transplantation?

Overall, the addition of PTCy to auto-HSCT represents a novel translational strategy with the potential to enhance immune resetting, suppress residual autoreactivity, and improve long-term remission rates in autoimmune disease patients.

Dietlinde Wolf, Robert B. Levy · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.